Cargando…

Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2

ABSTRACT: Coronavirus disease 2019 (COVID-19), resulting from infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause severe and fatal pneumonia along with other life-threatening complications. The COVID-19 pandemic has taken a heavy toll on the healthcare system glo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yong, Tian, Yu, Pan, Chenling, Liang, Aihua, Zhang, Wei, Sheng, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310681/ https://www.ncbi.nlm.nih.gov/pubmed/34308530 http://dx.doi.org/10.1007/s12539-021-00461-4

Ejemplares similares

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Therapeutic Application, Phytoactives and Pharmacology of Tinospora cordifolia: An Evocative Review
por: Ahsan, Rabiya, et al.
Publicado: (2023)

In Silico Multi-Target Approach Revealed Potential Lead Compounds as Scaffold for the Synthesis of Chemical Analogues Targeting SARS-CoV-2
por: Trezza, Alfonso, et al.
Publicado: (2022)

In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets
por: Duru, Chidi Edbert, et al.
Publicado: (2021)

Structure- and Ligand-Based in silico Studies towards the Repurposing of Marine Bioactive Compounds to Target SARS-CoV-2
por: Fayed, Marwa A.A., et al.
Publicado: (2021)

Targeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound
por: Eid, Jehane Ibrahim, et al.
Publicado: (2021)

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
por: Lin, Yu-Chao, et al.
Publicado: (2022)

Targeting SARS-CoV-2 Macrodomain-1 to Restore the Innate Immune Response Using In Silico Screening of Medicinal Compounds and Free Energy Calculation Approaches
por: Mohammad, Anwar, et al.
Publicado: (2023)

Natural Product-Based Screening for Lead Compounds Targeting SARS CoV-2 M(pro)
por: Chen, Jie, et al.
Publicado: (2023)

In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
por: Sivani, Bala Mohan, et al.
Publicado: (2021)

In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2
por: Alturki, Norah A., et al.
Publicado: (2022)

Therapeutic potential of compounds targeting SARS-CoV-2 helicase
por: Halma, Matthew T. J., et al.
Publicado: (2022)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study
por: Mishra, Ganesh Prasad, et al.
Publicado: (2021)

Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
por: Mahmud, Shafi, et al.
Publicado: (2021)

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
por: Chan, Wallace K. B., et al.
Publicado: (2022)

Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series
por: Umar, Sanusi, et al.
Publicado: (2022)

An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets
por: Thurakkal, Liya, et al.
Publicado: (2021)

Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
por: Zhang, Chuanming, et al.
Publicado: (2022)

In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023)

In silico study of the potential interactions of 4′-acetamidechalcones with protein targets in SARS-CoV-2
por: Q. Almeida-Neto, Francisco Wagner, et al.
Publicado: (2021)

Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
por: Nag, Anish, et al.
Publicado: (2021)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

Exploration of In-silico screening of therapeutic agents against SARS-CoV-2
por: Thakur, Yamini, et al.
Publicado: (2021)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Anticancer L-Asparaginase and Phytoactive Compounds From Plant Solanum nigrum Against MDR (Methicillindrug resistant) Staphylococcus aureus and Fungal Isolates
por: Aisha, Ambreen, et al.
Publicado: (2022)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
por: Yu, Pei-Chen, et al.
Publicado: (2022)

In silico screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases
por: Cheohen, Caio Felipe de Araujo Ribas, et al.
Publicado: (2023)

Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening
por: Li, Binjie, et al.
Publicado: (2023)

Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance
por: Zhang, Mengzi, et al.
Publicado: (2022)

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2
por: Liang, Hualou, et al.
Publicado: (2021)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020)

In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack
por: Hussein, Mouraya, et al.
Publicado: (2022)

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
por: Singh, Rajveer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3j8i4lia2gq7ao7la57vnau6ro